Ratings BIO-UV Group

Equities

ALTUV

FR0013345493

Market Closed - Euronext Paris Other stock markets 11:35:03 2024-05-03 am EDT			5-day change	1st Jan Change
2.255 ^EUR	+0.67%		-1.53%	-7.77%

Feb. 20	Bio-UV: partnership with U.S.-based Pinnacle Ozone	CF
Jan. 25	Bio-UV: return to growth forecast for 2024	CF

Strengths

Its low valuation, with P/E ratio at 5.57 and 4.9 for the ongoing fiscal year and 2024 respectively, makes the stock pretty attractive with regard to earnings multiples.
The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
Given the positive cash flows generated by its business, the company's valuation level is an asset.
For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The group shows a rather high level of debt in proportion to its EBITDA.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Electrical Components & Equipment

	1st Jan change	Capi.	ESG Refinitiv
BIO-UV GROUP	-7.77%	24.6M	-
SIEMENS AG	+4.53%	150B	A
SCHNEIDER ELECTRIC SE	+18.99%	130B	B+
EATON CORPORATION PLC	+33.09%	128B	B+
EMERSON ELECTRIC CO.	+9.46%	60.91B	A-
AMETEK, INC.	+1.01%	38.51B	B
VERTIV HOLDINGS CO	+93.59%	34.82B	C
WEG S.A.	+5.04%	32.09B	B
ROCKWELL AUTOMATION, INC.	-11.73%	31.4B	B
NIDEC CORPORATION	+27.37%	27.26B	B+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes